Flight-test nacelles

Design modifications for acoustically absorbing flight test nacelles of DC-8 turbofan engin

Amine-terminated nanoparticle films: pattern deposition by a simple nanostencilling technique and stability studies under X-ray irradiation

Exploring the surface chemistry of nanopatterned amine-terminated nanoparticle films.</p

Autumn MIST 2017

Jasmine Sandhu, Georgina Graham, Sarah Bentley and John Coxon report on the annual Magnetosphere, Ionosphere, and Solar–Terrestrial (MIST) meeting, highlighting science results from the Cassini and Juno missions

Constraining the variation of fundamental constants using 18cm OH lines

We describe a new technique to estimate variations in the fundamental constants using 18cm OH absorption lines. This has the advantage that all lines arise in the same species, allowing a clean comparison between the measured redshifts. In conjunction with one additional transition (for example, an HCO$^+$ line), it is possible to simultaneously measure changes in $\alpha$, $g_p$ and $y \equiv m_e/m_p$. At present, only the 1665 MHz and 1667 MHz lines have been detected at cosmological distances; we use these line redshifts in conjunction with those of HI 21cm and mm-wave molecular absorption in a gravitational lens at $z\sim 0.68$ to constrain changes in the above three parameters over the redshift range $0 < z \lesssim 0.68$. While the constraints are relatively weak ($\lesssim$ 1 part in $10^3$), this is the first simultaneous constraint on the variation of all three parameters. We also demonstrate that either one (or more) of $\alpha$, $g_p$ and $y$ must vary with cosmological time or there must be systematic velocity offsets between the OH, HCO$^+$ and HI absorbing clouds.Comment: 5 pages, no figures. Accepted for publication in Phys. Rev. Let

Experimental Calibration of a Numerical Model of Prepreg Tack for Predicting AFP Process Related Defects

Wrinkles, puckers, and fiber bridging are among the major defects encountered in the Automated Fiber Placement (AFP) process, and are all different manifestations of fiber misalignment. The main driver for these defects are the residual stresses introduced in the tow during the deposition stage by the AFP head. In contrast, the tack between the deposited tape and the substrate is the resisting force against the formation of such defects. Tack may be defined as the ability of a material to form a bond immediately on contact with another surface. Tack is a very complex phenomenon that is influenced by a variety of process parameters including temperature, head pressure and speed, as well as degree of cure, moisture content, and surface roughness A physics-based modeling framework for simulation of tack was developed in this study that allows for prediction of tack response. The developed tack model is incorporated in the AFP placement modelling framework developed to simulate AFP defects

Rotational Feshbach Resonances in Ultracold Molecular Collisions

In collisions at ultralow temperatures, molecules will possess Feshbach resonances, foreign to ultracold atoms, whose virtual excited states consist of rotations of the molecules. We estimate the mean spacing and mean widths of these resonant states, exploiting the fact the molecular collisions at low energy display chaotic motion. As examples, we consider the experimentally relevant molecules O_2, OH, and PbO. The density of s-wave resonant states for these species is quite high, implying that a large number of narrow resonant states will exist.Comment: 4 pages, 2 figure

National evaluation of the neighbourhood nurseries: integrated report

Report description: The NNI was launched in 2001 to provide high quality childcare in the most disadvantaged neighbourhoods of England, to help parents into employment, reduce child poverty and boost children’s development. By 2005 45,000 new childcare places had been created in approximately 1,400 neighbourhood nurseries. This report brings together the findings of the four individual strands of the National Evaluation of Neighbourhood Nurseries Initiative as shown above and makes a number of recommendations. The report shows the rationale for the government’s strategy in targeting disadvantaged neighbourhoods and in focusing on high quality childcare to provide the link between raising parental employment and income and improving children’s life chances

A phase II study of capecitabine and oxalplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract

Background: Advanced biliary tract carcinomas are associated with a poor prognosis, and palliative chemotherapy has only modest benefit. This multi-centre phase II study was conducted to determine the efficacy of capecitabine in combination with oxaliplatin in patients with inoperable gall bladder or biliary tract cancer. Methods: This was a Phase II, non-randomised, two-stage Simon design, multi-centre study. Ethics approval was sought and obtained by the North West MREC, and then locally by the West Glasgow Hospitals Research Ethics Com mittee. Eligible patients with inoperable locally advanced or metastatic adenocarcinoma of the gall bladder or biliary tract and with adequate performance status, haematologic, renal, and hepatic function were treated with capecit abine (1000 mg/m2 po, twice daily, days 1–14) and oxaliplatin (130 mg/m2 i.v., day 1) every 3 weeks for up to six cycles. The primary objective of the study was to determine the objective tumour response rates (complete and partial). The secondary objectives included assessment of toxicity, progression-free survival, and overall survival. Results: Forty-three patients were recruited between July 2003 and December 2005. The regimen was well tolerated with no grade 3/4 neutropenia or thrombocytopenia. Grade 3/4 sensory neuropathy was observed in six patients. Two-thirds of patients received their chemotherapy without any dose delays. Overall response rate was 23.8 % (95 % CI 12.05–39.5 %). Stable disease was observed in a further 13 patients (31 %) and progressive disease observed in 12 (28.6 %) of patients. The median progression-free survival was 4.6 months (95 % CI 2.8–6.4 months; Fig. 1) and the median overall survival 7.9 months (95 % CI 5.3–10.4 months; Fig. 2). Conclusion: Capecitabine combined with oxaliplatin has a lower disease control and shorter overall survival than the combination of cisplatin with gemcitabine which has subsequently become the standard of care in this disease. How ever, capecitabine in combination with oxaliplatin does have modest activity in this disease, and can be considered as an alternative treatment option for patients in whom cisplatin and/or gemcitabine are contra-indicated